Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01539382 · ClinicalTrials.gov registry record · NA

Measuring and Treating Brain Oxygen Levels in Open Heart Surgery

A NA study, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
140
Enrollment target

NCT01539382 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 140 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01539382, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
140 participants
Enrollment target

Study Summary

The purpose of this study is to test whether keeping the amount of oxygen delivered to the brain above a certain level during surgery and 24-hours after surgery improves recovery. Hypothesis 1: keeping the amount of oxygen delivered to the brain above a certain level during surgery and 24-hours after surgery improves cognitive and neurological outcomes after cardiac and aortic surgery. Hypothesis 2: keeping the amount of oxygen delivered to the brain above a certain level during surgery and 24-hours after surgery helps reduce major organ problems after cardiac and aortic surgery. To test our hypotheses, the investigators will conduct a randomized control trial. Patients will be randomly assigned to one of two possible study groups. In the Treatment Group, the brain oxygen level will be watched by doctors and used to guide care in the operating room and the first day in the intensive care unit after surgery. Doctors will try to keep the brain oxygen level in a normal range by adjusting your blood pressure, carbon dioxide and blood acidity levels, and blood count. In the Control Group, the doctors will not be aware of the brain oxygen level unless it falls below a level that may be dangerous. If a patient's brain oxygen falls below such a level, the doctors will adjust the blood pressure, carbon dioxide and blood acidity levels, and blood count to increase the brain oxygen level. All other procedures will be part of regular medical care and will be performed according to the standard of care.

Interventions

  • PROCEDURE Cerebral oxygenation intervention

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2011-11
Est. Completion 2014-12
Phase NA

What the Registry Record Tells You About NCT01539382

The ClinicalTrials.gov registry entry for NCT01539382 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Cerebral oxygenation intervention is the first listed.

NCT01539382 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01539382 about?

NCT01539382 is a clinical study titled "Measuring and Treating Brain Oxygen Levels in Open Heart Surgery". The purpose of this study is to test whether keeping the amount of oxygen delivered to the brain above a certain level during surgery and 24-hours after surgery improves recovery. Hypothesis 1: keeping the amount of oxygen delivered to the brain above a certain level during surgery and 24-hours aft...

What is the current status of trial NCT01539382?

This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2011-11. Estimated completion is 2014-12.

What interventions are being tested in trial NCT01539382?

The interventions under investigation include: Cerebral oxygenation intervention (PROCEDURE).

Who is sponsoring clinical trial NCT01539382?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.